Determination of sensitive and specific markers of very early AD progression is intended to aid researchers and clinicians to develop new treatments and monitor their effectiveness, as well as to lessen the time and cost of clinical trials. Magnetic Resonance (MR)-related biomarkers have been recently identified by the use of machine learning methods for the in vivo differential diagnosis of AD. However, the vast majority of neuroimaging papers investigating this topic are focused on the difference between AD and patients with mild cognitive impairment (MCI), not considering the impact of MCI patients who will (MCIc) or not convert (MCInc) to AD. Morphological T1-weighted MRIs of 137 AD, 76 MCIc, 134 MCInc, and 162 healthy controls (CN) selected from the Alzheimer's disease neuroimaging initiative (ADNI) cohort, were used by an optimized machine learning algorithm. Voxels influencing the classification between these AD-related pre-clinical phases involved hippocampus, entorhinal cortex, basal ganglia, gyrus rectus, precuneus, and cerebellum, all critical regions known to be strongly involved in the pathophysiological mechanisms of AD. Classification accuracy was 76% AD vs. CN, 72% MCIc vs. CN, 66% MCIc vs. MCInc (nested 20-fold cross validation). Our data encourage the application of computer-based diagnosis in clinical practice of AD opening new prospective in the early management of AD patients.

Salvatore, C., Cerasa, A., Battista, P., Gilardi, M., Quattrone, A., Castiglioni, I. (2015). Magnetic Resonance Imaging Biomarkers for the early diagnosis of Alzheimer's Disease: a machine learning approach. FRONTIERS IN NEUROSCIENCE, 9(sep) [10.3389/fnins.2015.00307].

Magnetic Resonance Imaging Biomarkers for the early diagnosis of Alzheimer's Disease: a machine learning approach

SALVATORE, CHRISTIAN
Primo
;
GILARDI, MARIA CARLA;CASTIGLIONI, ISABELLA
Ultimo
2015

Abstract

Determination of sensitive and specific markers of very early AD progression is intended to aid researchers and clinicians to develop new treatments and monitor their effectiveness, as well as to lessen the time and cost of clinical trials. Magnetic Resonance (MR)-related biomarkers have been recently identified by the use of machine learning methods for the in vivo differential diagnosis of AD. However, the vast majority of neuroimaging papers investigating this topic are focused on the difference between AD and patients with mild cognitive impairment (MCI), not considering the impact of MCI patients who will (MCIc) or not convert (MCInc) to AD. Morphological T1-weighted MRIs of 137 AD, 76 MCIc, 134 MCInc, and 162 healthy controls (CN) selected from the Alzheimer's disease neuroimaging initiative (ADNI) cohort, were used by an optimized machine learning algorithm. Voxels influencing the classification between these AD-related pre-clinical phases involved hippocampus, entorhinal cortex, basal ganglia, gyrus rectus, precuneus, and cerebellum, all critical regions known to be strongly involved in the pathophysiological mechanisms of AD. Classification accuracy was 76% AD vs. CN, 72% MCIc vs. CN, 66% MCIc vs. MCInc (nested 20-fold cross validation). Our data encourage the application of computer-based diagnosis in clinical practice of AD opening new prospective in the early management of AD patients.
Articolo in rivista - Articolo scientifico
machine learning, Alzheimer
English
2015
9
sep
307
open
Salvatore, C., Cerasa, A., Battista, P., Gilardi, M., Quattrone, A., Castiglioni, I. (2015). Magnetic Resonance Imaging Biomarkers for the early diagnosis of Alzheimer's Disease: a machine learning approach. FRONTIERS IN NEUROSCIENCE, 9(sep) [10.3389/fnins.2015.00307].
File in questo prodotto:
File Dimensione Formato  
10281-88527.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 2.72 MB
Formato Adobe PDF
2.72 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/88527
Citazioni
  • Scopus 177
  • ???jsp.display-item.citation.isi??? 151
Social impact